This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
OCD increases risk of death from natural and unnatural causes, Swedish study finds
Read more
Talazoparib recommended by NICE for advanced breast cancer after initial rejection
Read more
Only prescribe fluoroquinolone antibiotics as last resort, says MHRA drug safety update
Read more
SC atezolizumab gains EU marketing authorisation for multiple cancer types
Read more
Empagliflozin recommended by NICE as add-on to standard care in CKD
Read more
Medicines regulators take action over risk of autism for children whose fathers took valproate
Read more
Covid-19 undervaccination led to thousands of deaths in UK, research shows
Read more
Blood protein test could ‘kickstart’ new generation of early cancer detection
Read more
Adolescent cholesterol checks may reduce premature heart damage and death
Read more
Takotsubo cardiomyopathy consistently treated incorrectly, study finds
Read more
NICE recommends huge expansion of Covid-19 antiviral eligibility in at-risk groups
Read more
Significant shortfalls in recommended asthma follow-up care after hospitalisation
Read more
EU sees launch of foslevodopa-foscarbidopa for advanced Parkinson’s disease
Read more
Best practice strategies for improving institutional fluid stewardship
Read more
Health inequalities led to one million early deaths in England in 2010s, as Europe fared better
Read more
Bevacizumab plus chemotherapy shown to improve paediatric neuroblastoma outcomes
Read more
PARP inhibitor talazoparib combined with enzalutamide approved in EU for prostate cancer
Read more
Page 6 of 200
« First
«
...
4
5
6
7
8
...
20
30
40
...
»
Last »
Popular articles
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
x
Search for: